CLINICAL_TRIALS
trial_result
· 2026-08-26
Clinical Trial Results: Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating therapies for metastatic castration-resistant prostate cancer has terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amgen | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2026-08-26